Clinical Trials Browser

Phase 2 × Prolactinoma × Endocrine × Clear all

Adenoma, Basophil, Adenoma, Chromophobe, Adenoma, Acidophil, Pituitary Neoplasms, Prolactinoma, Central Nervous System Neoplasms, Growth Hormone-Secreting Pituitary Adenoma

NCT00939523 2020-01-22

Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy

Phase 2 Completed

9 enrolled 11 charts

Endocrine

Pituitary Neoplasms, Prolactinoma

Clinical Trials

Temozolomide in Treating Patients With Invasive Pituitary Tumors

Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy